Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p38 MAPK in development and cancer.

Cynthia Bradham1, David R McClay

  • 1DCMB Group, Duke University, Durham, North Carolina, USA. cabrad@duke.edu

Cell Cycle (Georgetown, Tex.)
|April 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wnt dynamics at the blastopore and stomodeum during sea urchin gastrulation.

Development (Cambridge, England)·2026
Same author

Author Correction: A molecular basis for spine color morphs in the sea urchin Lytechinus variegatus.

Scientific reports·2025
Same author

Reprogramming of cells during embryonic transfating: overcoming a reprogramming block.

Development (Cambridge, England)·2024
Same author

Single-Cell Transcriptomics Reveals Evolutionary Reconfiguration of Embryonic Cell Fate Specification in the Sea Urchin Heliocidaris erythrogramma.

Genome biology and evolution·2024
Same author

A molecular basis for spine color morphs in the sea urchin Lytechinus variegatus.

Scientific reports·2024
Same author

Contrasting the development of larval and adult body plans during the evolution of biphasic lifecycles in sea urchins.

Development (Cambridge, England)·2024
Same journal

Circular RNA circ_0001829 attenuates G2/M arrest to promote hepatocyte proliferation by sponging miR-3095-3p following liver injury.

Cell cycle (Georgetown, Tex.)·2026
Same journal

Identification of PGF+ endothelial cells associated with plaque instability in carotid atherosclerosis by scRNA-seq and RNA-seq analysis.

Cell cycle (Georgetown, Tex.)·2026
Same journal

BMSCs-derived exosomal miR-196a-5p promotes macrophage M2 polarization and osteogenesis in postmenopausal osteoporosis through regulating Rspo2/Wnt/β-catenin signaling.

Cell cycle (Georgetown, Tex.)·2026
Same journal

MicroRNA-6833-3p drives prostate cancer progression and stemness by targeting the NUMB-mediated NOTCH signaling pathway.

Cell cycle (Georgetown, Tex.)·2026
Same journal

OTUD5 promotes AML progression by stabilizing SLC7A11 to suppress ferroptosis.

Cell cycle (Georgetown, Tex.)·2026
Same journal

MITF-Driven melanoma plasticity as a core mechanism of therapy resistance: integrating microenvironmental signaling, mechanotransduction, and metabolic reprogramming.

Cell cycle (Georgetown, Tex.)·2026
See all related articles

p38 mitogen-activated protein kinase (MAPK) regulates diverse cellular processes, with context-dependent effects on apoptosis and cell cycle. In vivo studies reveal its crucial roles in embryonic development and cancer progression, highlighting its potential as a therapeutic target.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • p38 MAPK is a key signaling molecule with diverse cellular effects.
  • Its functions in apoptosis and cell cycle regulation are context-dependent.
  • p38 was initially identified for its role in cytokine induction and inflammation.

Purpose of the Study:

  • To review the in vivo functions of p38 MAPK.
  • To provide perspective on p38's biological roles.
  • To evaluate p38 as a pharmacological target.

Main Methods:

  • Review of in vivo studies on p38 MAPK.
  • Analysis of p38's role in embryonic development.
  • Evaluation of p38's involvement in cancer progression.

Related Experiment Videos

Main Results:

  • p38 MAPK exhibits context-specific effects on apoptosis and cell cycle.
  • In vivo studies demonstrate p38's critical role in embryonic development.
  • p38 is implicated as a significant regulator of cancer progression.

Conclusions:

  • p38 MAPK is a vital regulator in vivo.
  • Understanding p38's in vivo functions is crucial for therapeutic development.
  • p38 represents a promising pharmacological target for various diseases.